Trunity Partners Founder Mona Zhang Proposed for Election to the Board of Moberg Pharma AB (publ)

September 3, 2025

Trunity Partners Ltd.

Toronto, Canada – September 3, 2025 – Trunity Partners Ltd., a portfolio management firm registered with the Ontario Securities Commission in Canada, is pleased to announce that its Founder and Managing Partner, Mona Zhang, has been proposed by shareholders for election to the Board of Directors of Moberg Pharma AB (publ), a Swedish specialty pharma company listed on Nasdaq Stockholm (OMX: MOB).


The election will take place at Moberg Pharma’s Extraordinary General Meeting (EGM) on September 29, 2025 in Stockholm. If approved, Mona Zhang will serve on the board until the next Annual General Meeting in 2026.


Mona Zhang brings over 15 years of experience in global investment management and corporate governance. She is the Founder and Managing Partner of Trunity Partners Ltd., a portfolio management firm registered with the Ontario Securities Commission in Canada. Previously, she worked at Mackenzie Investments and Burgundy Asset Management, focusing on equity research and investing in high-quality compounders with a long-term perspective. Today, she also serves on the boards of the Canadian Business History Association and the International Agama Zen Practice Centre, and is a guest lecturer at the Rotman School of Management, University of Toronto. She is a CFA charterholder.


About Moberg Pharma AB (publ) Moberg Pharma AB is a Swedish dermatology company headquartered in Stockholm and listed on Nasdaq Stockholm. The company specializes in developing and commercializing innovative topical treatments based on proven active ingredients. Its flagship product is MOB-015 (Terclara®), a next-generation topical treatment for onychomycosis (nail fungus).



  • Market Leadership: Since its launch in Sweden in 2024, Terclara® has become the market leader, reaching a 31% share. In 2025, Terclara® also achieved market leadership in Norway, with pharmacy sell-in market shares of up to 48% by value and 45% by units, making it the leading product in both Sweden and Norway.
  • Launch Strategy: Success in both markets has been driven by broad pharmacy distribution, targeted consumer marketing, and close collaboration with healthcare professionals and pharmacy chains.
  • Geographic Reach: MOB-015/Terclara® has been approved in 13 European countries and launched OTC in 7 markets, with expansion ongoing across Europe, North America, and Asia.


Disclaimer The proposed election of Mona Zhang is subject to shareholder approval at the Extraordinary General Meeting on September 29, 2025. There can be no assurance that the proposal will be approved. This press release is provided for informational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities.

Trunity Partners宣布Trunity Hexagon Model™获得加拿大商标批准

August 11, 2025
多伦多，2025年8月10日 —— 加拿大独立投资管理公司 Trunity Partners Ltd. 正式宣布，其自主研发的投资分析框架 Trunity Hexagon Model™ 已获得加拿大知识产权局（Canadian Intellectual Property Office, CIPO）批准注册为商标（注册号 2325810，当前使用™标识）。 此次批准标志着Trunity Partners在投资研究方法论上的独创性与系统性，得到了权威机构的正式认可和法律保护。 Trunity Hexagon Model™ 由Trunity创始人及管理合伙人 Mona Zhang, CFA, MBA 带领团队历经多年打磨而成，核心涵盖六大关键维度： 价值主张（Value Proposition） 商业模型（Business Model） 竞争优势（Competitive Advantage） 增长曲线（Runway & Growth Potential） 团队与文化（People and Culture） 内含价值计算（Valuation & Financials） 这一框架广泛应用于公司在全球范围内筛选与评估长期复利型企业（Global Compounders）的投资实践中，帮助客户在不同市场环境中保持投资纪律性，抓住穿越周期的增长机会。 Mona Zhang 表示： “Trunity Hexagon Model™ 不仅是一套分析工具，更是我们与客户共享的投资语言与思维框架。此次获得加拿大商标批准，是对我们研究深度、原创性和专业水准的肯定，也将为客户带来更有保障、更具体系化的投资决策支持。” 未来，Trunity Partners计划将该框架应用于更多跨境投资与家族财富管理场景，并通过旗下 Trunity Hexagon Program 教育与赋能下一代商业领袖，实现财富与智慧的共同传承。 Media Contact / 媒体联络 Trunity Partners Ltd. 📍 2700 - 161 Bay Street, Toronto, ON, M5J 2S1 📞 +1 647-280-1718 🌐 www.trunitypartners.com 📧 info@trunitypartners.com

Trunity Partners Announces Canadian Trademark Approval for Trunity Hexagon Model™

August 11, 2025
Toronto, August 10, 2025 – Trunity Partners Ltd. , an independent investment management firm based in Canada, is proud to announce that its proprietary investment analysis framework, the Trunity Hexagon Model™ , has been officially approved by the Canadian Intellectual Property Office (CIPO) for trademark registration (Registration No. 2325810, currently using the ™ designation). This approval marks official recognition and legal protection for the originality and systematic approach behind Trunity Partners’ investment research methodology. The Trunity Hexagon Model™ , developed and refined over years under the leadership of Mona Zhang, CFA, MBA , Founder and Managing Partner of Trunity Partners, encompasses six key dimensions: Value Proposition Business Model Competitive Advantage Runway & Growth Potential People and Culture Valuation & Financials Widely applied in the firm’s global search for and assessment of long-term compounding businesses, the framework helps clients maintain investment discipline and capture growth opportunities across market cycles. Mona Zhang commented: “The Trunity Hexagon Model™ is more than just an analytical tool—it is a shared investment language and mindset that we bring to our clients. Trademark approval in Canada affirms the depth, originality, and professionalism of our research, and further strengthens the value and structure we provide to client investment decisions.” Looking ahead, Trunity Partners plans to apply this framework across more cross-border investment and family wealth management contexts, while leveraging the Trunity Hexagon Program to educate and empower the next generation of business leaders—ensuring the continuity of both wealth and wisdom.

Q12024 Investment Review

By test • November 7, 2019
This is a subtitle for your new post